. Author manuscript; available in PMC: 2012 Jan 30.

Published in final edited form as: Clin Chim Acta. 2010 Oct 27;412(3-4):277–285. doi: 10.1016/j.cca.2010.10.018

Table 1.

List of advanced glycation end products and early stage glycation products considered in this study.

Glycation adducts involving lysine	Abbreviation	Δm (Da)
Fructosyl-lysine	FL	162.05
Fructosyl-lysine-1H₂O	FL-1H₂O	144.04
Fructosyl-lysine-2H₂O	FL-2H₂O	126.03
N_ε-Carboxyethyl-lysine	CEL	72.02
N_ε-Carboxymethyl-lysine	CML	58.01
Pyrraline	Pyr	108.02

Glycation adducts involving arginine	Abbreviation	Δm (Da)
N_ε-[5-(2,3,4-Trihydroxybutyl)-5-hydro-4-imidazolon-2-yl]ornithine	3-DG-H1	144.04
Tetrahydropyrimidine	THP	144.04
Imadazolone B	IB	142.03
Argpyrimidine	ArgP	80.03
N_ε-(5-Hydro-5-methyl-4-imidazolon-2-yl)ornithine	MG-H1	54.01
N_ε-(5-Hydro-4-imidazolon-2-yl)ornithine	G-H1	39.99

Glycation adducts involving both lysine and arginine	Abbreviation	Δm (Da)
1-Alkyl-2-formyl-3,4-glycosyl-pyrrole	AFGP	270.07